Application Nr Approved Date Route Status External Links
ANDA201760 None Sublingual None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Buprenorphine Sublingual Tablet Is Indicated For The Treatment Of Opioid Dependence And Is Preferred For Induction. Buprenorphine Sublingual Tablet Should Be Used As Part Of A Complete Treatment Plan To Include Counseling And Psychosocial Support. Buprenorphine Sublingual Tablet, Contains Buprenorphine, A Partial Opioid Agonist, And Is Indicated For The Treatment Of Opioid Dependence And Is Preferred For Induction. (1) Buprenorphine Sublingual Tablet Should Be Used As Part Of A Complete Treatment Plan That Includes Counseling And Psychosocial Support. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Buprenorphine Hydrochloride BUPRENORPHINE HYDROCHLORIDE ZINC100373348

Comments